IL135123A0 - Parenteral formulations comprising carbamazepine or its derivatives - Google Patents

Parenteral formulations comprising carbamazepine or its derivatives

Info

Publication number
IL135123A0
IL135123A0 IL13512398A IL13512398A IL135123A0 IL 135123 A0 IL135123 A0 IL 135123A0 IL 13512398 A IL13512398 A IL 13512398A IL 13512398 A IL13512398 A IL 13512398A IL 135123 A0 IL135123 A0 IL 135123A0
Authority
IL
Israel
Prior art keywords
carbamazepine
derivatives
parenteral formulations
parenteral
formulations
Prior art date
Application number
IL13512398A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL135123A0 publication Critical patent/IL135123A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL13512398A 1997-10-09 1998-10-07 Parenteral formulations comprising carbamazepine or its derivatives IL135123A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721497.7A GB9721497D0 (en) 1997-10-09 1997-10-09 Organic compounds
PCT/EP1998/006382 WO1999018966A1 (en) 1997-10-09 1998-10-07 Parenteral formulations comprising carbamazepine or its derivatives

Publications (1)

Publication Number Publication Date
IL135123A0 true IL135123A0 (en) 2001-05-20

Family

ID=10820342

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13512398A IL135123A0 (en) 1997-10-09 1998-10-07 Parenteral formulations comprising carbamazepine or its derivatives

Country Status (32)

Country Link
US (2) US6316417B1 (pt)
EP (1) EP1033988B1 (pt)
JP (2) JP2001519395A (pt)
KR (1) KR100760326B1 (pt)
CN (1) CN1210032C (pt)
AR (1) AR015465A1 (pt)
AT (1) ATE257383T1 (pt)
AU (1) AU748034B2 (pt)
BR (1) BR9812861A (pt)
CA (1) CA2304661C (pt)
CO (2) CO5090854A1 (pt)
CZ (1) CZ298900B6 (pt)
DE (1) DE69821024T2 (pt)
DK (1) DK1033988T3 (pt)
ES (1) ES2214738T3 (pt)
GB (1) GB9721497D0 (pt)
HK (1) HK1031824A1 (pt)
HU (1) HU226106B1 (pt)
ID (1) ID24134A (pt)
IL (1) IL135123A0 (pt)
MY (1) MY122129A (pt)
NO (1) NO327263B1 (pt)
NZ (1) NZ503526A (pt)
PE (1) PE121998A1 (pt)
PL (1) PL192287B1 (pt)
PT (1) PT1033988E (pt)
RU (1) RU2242231C2 (pt)
SK (1) SK286253B6 (pt)
TR (1) TR200000870T2 (pt)
TW (1) TW584563B (pt)
WO (1) WO1999018966A1 (pt)
ZA (1) ZA989183B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
SI1928464T1 (sl) * 2005-09-30 2014-09-30 Lundbeck Inc. Nova parenteralna karbamazepinska formulacija
US20100204178A1 (en) * 2006-10-02 2010-08-12 James Cloyd Novel parenteral carbamazepine formulation
JP5528708B2 (ja) * 2006-02-09 2014-06-25 参天製薬株式会社 安定な製剤ならびにそれらを調製および使用する方法
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
CN101711739B (zh) * 2008-10-08 2012-07-04 中国人民解放军军事医学科学院毒物药物研究所 卡马西平的口服药物组合物
CN105726466A (zh) * 2014-12-10 2016-07-06 辽宁药联制药有限公司 一种奥卡西平注射剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0435825T3 (da) * 1989-12-27 1996-02-12 Ciba Geigy Ag Apparat til homogenisering af den inhomogene lysfordeling i et laserstrålelysbundt
EP0435826A1 (de) * 1989-12-27 1991-07-03 Ciba-Geigy Ag Intravenöse Lösungen für Status Epilepticus
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5231089A (en) * 1991-12-02 1993-07-27 University Of Florida Method of improving oral bioavailability of carbamazepine
FR2702148B1 (fr) 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US5466683A (en) * 1994-08-25 1995-11-14 Teva Pharmaceutical Industries Ltd. Water-soluble analogs of carbamazepine

Also Published As

Publication number Publication date
CZ20001279A3 (cs) 2000-07-12
JP2005281314A (ja) 2005-10-13
DE69821024D1 (de) 2004-02-12
NO20001730D0 (no) 2000-04-04
CZ298900B6 (cs) 2008-03-05
HK1031824A1 (en) 2001-06-29
NO20001730L (no) 2000-04-04
AR015465A1 (es) 2001-05-02
HUP0004362A2 (hu) 2001-08-28
ES2214738T3 (es) 2004-09-16
CN1274286A (zh) 2000-11-22
CA2304661A1 (en) 1999-04-22
ID24134A (id) 2000-07-06
KR100760326B1 (ko) 2007-09-20
ZA989183B (en) 1999-04-09
BR9812861A (pt) 2000-08-08
NZ503526A (en) 2003-01-31
DE69821024T2 (de) 2004-10-28
PE121998A1 (es) 1999-12-08
TW584563B (en) 2004-04-21
PL339446A1 (en) 2000-12-18
US6458770B1 (en) 2002-10-01
EP1033988B1 (en) 2004-01-07
EP1033988A1 (en) 2000-09-13
RU2242231C2 (ru) 2004-12-20
TR200000870T2 (tr) 2000-10-23
SK5052000A3 (en) 2000-12-11
SK286253B6 (sk) 2008-06-06
CA2304661C (en) 2007-12-11
HUP0004362A3 (en) 2006-06-28
JP2001519395A (ja) 2001-10-23
US20020055503A1 (en) 2002-05-09
CO4950520A1 (es) 2000-09-01
AU9629898A (en) 1999-05-03
WO1999018966A1 (en) 1999-04-22
US6316417B1 (en) 2001-11-13
MY122129A (en) 2006-03-31
CO5090854A1 (es) 2001-10-30
AU748034B2 (en) 2002-05-30
NO327263B1 (no) 2009-05-25
GB9721497D0 (en) 1997-12-10
HU226106B1 (en) 2008-04-28
CN1210032C (zh) 2005-07-13
DK1033988T3 (da) 2004-04-13
PL192287B1 (pl) 2006-09-29
PT1033988E (pt) 2004-05-31
KR20010072533A (ko) 2001-07-31
ATE257383T1 (de) 2004-01-15

Similar Documents

Publication Publication Date Title
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
HUP0003642A3 (en) N-alkanoylphenylalanine derivatives
GB9702194D0 (en) Sulphonide derivatives
ZA987602B (en) N-alkanoylphenylalanine derivatives
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
IL128027A0 (en) Benzosulfone derivatives
GB9809664D0 (en) a-Ketoamide derivatives
HUP9801168A3 (en) Triazinylaminostilbene derivatives
IL135519A0 (en) 2-halo-6-0-substituted ketolide derivatives
ZA9810559B (en) Carbohydrate derivatives
EG23802A (en) 2-Phenylpyran-4-one derivatives
IL132982A0 (en) Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
GB9715821D0 (en) Amidino-camptothecin derivatives
HUP0004362A3 (en) Parenteral formulations comprising carbamazepine or its derivatives
GB2321457B (en) 5-Aroylnaphthalene derivatives
GB9827729D0 (en) Thieno-indole derivatives
ZA98611B (en) Imino-aza-anthracyclinone derivatives
GB9725541D0 (en) Amino-benzothiazole derivatives
EP1044985A4 (en) ERYTHROMYCIN DERIVATIVES
ZA983116B (en) Arylsecocholadiene derivatives
EP1061912A4 (en) PHENANTHROFURANDERIVATE
IL131159A0 (en) 4-Aminoethoxyindazole derivatives
GB9706753D0 (en) Aralkoxy-morphinan derivatives
SI1005445T1 (en) N-alkanoylphenylalanine derivatives
ZA983700B (en) 1-galactose derivatives